Ventral Pallidum Circuits Underlying Preclinical Models of Opioid Addiction
Ventral Pallidum Circuits Underlying Preclinical Models of Opioid Addiction
批准号:
10587642
负责人:
Stephen Vincent Mahler
金额:
$31.9万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2028-01-31
关键词:
AbstinenceAmericanAnimal ModelAnimalsAttentionBehaviorBehavior DisordersBehavioralBrainChronicCuesDangerousnessDarknessDataDesire for foodDiseaseDrug usageEconomicsElasticityEssential DrugsFailureGeneticGlobus PallidusHabenulaHalf-LifeHeroinHumanIndividualInterventionKnowledgeLateralLearningLifeMeasuresMediatingModelingMotivationNeuronsNeurosciencesOccupationsOpiate AddictionOpioidOutputPathway interactionsPerformancePharmaceutical PreparationsPlayPositioning AttributePre-Clinical ModelProcessPsychological reinforcementPunishmentRat TransgeneRattusRelapseRewardsRodentRodent ModelRoleScourgeShockSideSymptomsTestingVentral Tegmental AreaWithdrawalWithdrawal Symptomaddictioncocaine relapsedrug actionexperiencefentanyl analoggamma-Aminobutyric Acidgenetic manipulationhedonicheroin usemotivated behaviorneural networknovel therapeuticsopioid epidemicopioid use disorderpreclinical studyremifentanilsegregationstemtooltreatment strategy
中文摘要
项目摘要
成瘾,特别是阿片类药物使用障碍(OUD),是美国人生活中的一个祸害。虽然我们知道很多
从阿片类药物如何作用于大脑的动物模型,我们还没有开发出新的OUD治疗方法,
在这个知识。为什么会这样呢?我们的实验室,像近年来的其他实验室一样,认为部分原因是缺乏
捕获成瘾的关键行为特征的预防性相关啮齿动物模型,例如
适应不良,强迫性和复发性使用,在一个子集的个人发展。
在人类中,OUD的特征是持续使用阿片类药物,尽管有负面后果,
使用这些药物,戒烟后复发,以及长期使用海洛因等阿片类药物,
使用、耐受和撤回的升级。每一种与预防相关的行为现象都可以
现在可以在啮齿类动物中建模,但对它们各自背后的神经网络却知之甚少。
腹侧苍白球(VP),特别是其向腹侧被盖区(VTA)的致密投射,
由于其在动机和成瘾方面的强大作用而引起越来越多的关注。我们最近展示了VP神经元
是必不可少的预防相关的可卡因复发样行为,GABA能VP神经元(VPGABA)
他们对VTA的预测具体负责一系列强烈动机的行为--大概是这样
通过与更广泛的动机神经网络的相互作用。我们希望通过了解这些神经元
网络在捕捉OUD关键方面的行为过程中发挥作用,我们可以利用这些信息来开发
基于神经科学的新治疗策略
在这里,我们系统地剖析了VPGABA神经元的参与,以及更广泛的奖励和厌恶,
网络,他们调节,在OUD相关的行为。在经过充分验证的GAD 1:Cre转基因大鼠中,我们使用Cre
和Flp依赖的化学遗传学操作,以显示VPGABA神经元1)调节更广泛的网络
潜在的阿片类药物复发,2)通过其功能分离的输出参与OUD的食欲方面,
以及3)这些途径如何介导OUD的令人厌恶的方面。我们假设VPGABA神经元调节
更广泛的神经网络来产生OUD行为,抑制这一关键途径将减少强迫性行为。
药物寻求
英文摘要
Project Summary
Addiction, and opioid use disorder (OUD) in particular, is a scourge on American life. Though we know much
from animal models about how opioid drugs act on the brain, we have yet to develop new OUD treatments based
on this knowledge. Why is this? Our lab, like others in recent years, have argued that in part it is due to a lack of
translationally-relevant rodent models that capture the key behavioral features of addiction, such as the
maladaptive, compulsive, and relapsing use that develops in a subset of individuals.
In humans, OUD is characterized by continued use of opioids despite negative consequences, preoccupation
with using these drugs, and relapse to drug use after quitting, and for long-lasting opioids like heroin, also
escalation of use, tolerance, and withdrawal. Each of these translationally-relevant behavioral phenomena can
now be modelled in rodents, but the neural networks underlying each of them are yet poorly understood.
The ventral pallidum (VP), and especially its dense projections to the ventral tegmental area (VTA), have
drawn increasing attention for their potent roles in motivation and addiction. We recently showed VP neurons
are essential for translationally-relevant cocaine relapse-like behavior, and that GABAergic VP neurons (VPGABA)
and their projections to VTA are specifically responsible for a range of strongly motivated behaviors—presumably
via interactions with wider neural networks of motivation. We hope that by understanding how these neural
networks function during behaviors that capture key aspects of OUD, we can leverage this information to develop
new neuroscience-based treatment strategies.
Here, we systematically dissect the involvement of VPGABA neurons, and the wider reward and aversion
networks they modulate, in OUD-relevant behaviors. In well-validated GAD1:Cre transgenic rats, we use Cre
and Flp-dependent chemogenetic manipulations to show how VPGABA neurons 1) modulate wider networks
underlying opioid relapse, 2) participate via their functionally-segregated outputs in appetitive aspects of OUD,
and 3) how these pathways mediate aversive aspects of OUD. We hypothesize that VPGABA neurons modulate
wider neural networks to generate OUD behaviors, and that inhibiting this key pathway will reduce compulsive
drug seeking.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ICAL: Impact of Cannabinoids Across Lifespan: Animal Core
-
批准号:10188475
-
项目类别:
-
资助金额:$51.48万
-
财政年份:2018
-
负责人:Stephen Vincent Mahler
-
依托单位:
ICAL: Impact of Cannabinoids Across Lifespan: Behavioral Project
-
批准号:10188480
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2018
-
负责人:Stephen Vincent Mahler
-
依托单位:
Role of Ventral Pallidum Projection to VTA in Reinstatement of Cocaine Seeking
-
批准号:9479923
-
项目类别:
-
资助金额:$0.92万
-
财政年份:2015
-
负责人:Stephen Vincent Mahler
-
依托单位:
Role of Ventral Pallidum Projection to VTA in Reinstatement of Cocaine Seeking
-
批准号:8990066
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2015
-
负责人:Stephen Vincent Mahler
-
依托单位:
Role of Ventral Pallidum Projection to VTA in Reinstatement of Cocaine Seeking
-
批准号:8488038
-
项目类别:
-
资助金额:$12.01万
-
财政年份:2013
-
负责人:Stephen Vincent Mahler
-
依托单位:
VTA Glutamate and Orexin Involvement in Cue Reinstatement of Drug Seeking
-
批准号:8214611
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2010
-
负责人:Stephen Vincent Mahler
-
依托单位:
VTA Glutamate and Orexin Involvement in Cue Reinstatement of Drug Seeking
-
批准号:7805892
-
项目类别:
-
资助金额:$4.56万
-
财政年份:2010
-
负责人:Stephen Vincent Mahler
-
依托单位:
VTA Glutamate and Orexin Involvement in Cue Reinstatement of Drug Seeking
-
批准号:8019989
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2010
-
负责人:Stephen Vincent Mahler
-
依托单位:
Opioid Modulation of Cue-Triggered 'Wanting' in Amygdala
-
批准号:7496517
-
项目类别:
-
资助金额:$1.87万
-
财政年份:2006
-
负责人:Stephen Vincent Mahler
-
依托单位:
Opioid Modulation of Cue-Triggered 'Wanting' in Amygdala
-
批准号:7298601
-
项目类别:
-
资助金额:$3.26万
-
财政年份:2006
-
负责人:Stephen Vincent Mahler
-
依托单位:
Opioid Modulation of Cue-Triggered 'Wanting' in Amygdala
-
批准号:7218363
-
项目类别:
-
资助金额:$3.26万
-
财政年份:2006
-
负责人:Stephen Vincent Mahler
-
依托单位:
海外基金